Several pediatric DCM cohorts have identified risk factors for adverse outcomes, including older age (> 6 years), lower LV fractional shortening, heart failure at presentation, idiopathic DCM, and elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) levels. This evidence concerns the gene NPPB and familial dilated cardiomyopathy.